Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 32131301000001111 | Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 32131401000001115 | Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category Schedule 2 (CD) | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Is a | Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Has active ingredient | Opium | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Has active ingredient | Scopolamine hydrobromide | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Has active ingredient | Papaveretum | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Has specific active ingredient | Scopolamine hydrobromide | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Has specific active ingredient | Papaveretum | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Is a | Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | false | Inferred relationship | Existential restriction modifier | ||
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Is a | Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule | Is pack of | False | Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Inferred relationship | Existential restriction modifier | |
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule | Has AMP | True | Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR